0RPS Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 174.60 |
| 52 Week High | SEK 206.50 |
| 52 Week Low | SEK 129.40 |
| Beta | 1.46 |
| 11 Month Change | -8.20% |
| 3 Month Change | -5.01% |
| 1 Year Change | 20.51% |
| 33 Year Change | -39.27% |
| 5 Year Change | 61.34% |
| Change since IPO | 166.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RPS | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -3.4% | -3.9% | -0.3% |
| 1Y | 20.5% | -24.2% | 6.1% |
Return vs Industry: 0RPS exceeded the UK Healthcare industry which returned -23.8% over the past year.
Return vs Market: 0RPS exceeded the UK Market which returned 5.6% over the past year.
Price Volatility
| 0RPS volatility | |
|---|---|
| 0RPS Average Weekly Movement | 3.7% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RPS has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0RPS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,000 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| 0RPS fundamental statistics | |
|---|---|
| Market cap | SEK 26.15b |
| Earnings (TTM) | SEK 227.90m |
| Revenue (TTM) | SEK 23.11b |
114.8x
P/E Ratio1.1x
P/S RatioIs 0RPS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RPS income statement (TTM) | |
|---|---|
| Revenue | €2.00b |
| Cost of Revenue | €1.58b |
| Gross Profit | €413.60m |
| Other Expenses | €393.90m |
| Earnings | €19.70m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 20.70% |
| Net Profit Margin | 0.99% |
| Debt/Equity Ratio | 121.9% |
How did 0RPS perform over the long term?
See historical performance and comparison